Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of genital warts with interferon alpha-2b cream
2005-000162-40Phase 2Completed
- Sponsor
- Helix Product Development
- Start
- Aug 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of interferon alfa-2b in anogenital warts, sponsored by Helix Product Development. Primary endpoint: Complete clearance of baseline warts. Started Aug 2005; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
anogenital warts
Beyond the preview
Go deeper on 2005-000162-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000162-40.